delayed-type hypersensitivity


Also found in: Dictionary, Acronyms, Encyclopedia.

delayed-type hypersensitivity (DTH)

a delayed hypersensitivity. See also cell-mediated immune response.
References in periodicals archive ?
The criterion for using Burulin and PPD dual testing to confirm clinical cases of BU has been reported (3,9), and the cumulative delayed-type hypersensitivity (DTH) findings for this study have been described (Table 1) (3).
In addition, the data showed a significant correlation between survival and delayed-type hypersensitivity (DTH) responsiveness to patients' unmodified tumor cells (P<.
Patients will be evaluated for safety and for the development of an immune response to autologous melanoma cells, as measured by delayed-type hypersensitivity (DTH).
Twenty-five patients were evaluated for enhanced antitumor immunity as measured by delayed-type hypersensitivity (DTH) skin reactions following treatment with GVAX(R) melanoma vaccine, and 17 of the 25 patients (68 percent) demonstrated induction of immunologic reactivity against their tumors by the DTH test.
Eighteen of 22 patients who completed the entire course of vaccinations demonstrated enhanced antitumor immunity as measured by delayed-type hypersensitivity (DTH) skin reactions following treatment with GVAX(R) lung cancer vaccine.
Eighteen of 25 patients who received the complete course of vaccinations demonstrated enhanced antitumor immunity as measured by delayed-type hypersensitivity (DTH) skin reactions.
The response was measured by performing a delayed-type hypersensitivity (DTH) skin test using the patients' own melanoma cells.
In summary, the data presented demonstrate that patients treated with M-Vax develop delayed-type hypersensitivity (DTH) indicating an immune reaction to autologous melanoma cells.
All patients were tested for delayed-type hypersensitivity (DTH), a measure of the activity of T-lymphocytes (i.
Another common reaction to NRL products is allergic contact dermatitis, also known as delayed-type hypersensitivity.